Skip to main content
Dechra Pharmaceuticals PLC logo

Dechra Pharmaceuticals PLC — Investor Relations & Filings

Ticker · DPH ISIN · US2434351043 LEI · 213800J4UVB5OWG8VX82 IL Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2022-08-30 Regulatory Filings
Country GB United Kingdom
Listing IL DPH

About Dechra Pharmaceuticals PLC

https://www.dechra.com/

Dechra Pharmaceuticals PLC is a global specialist business focused on veterinary pharmaceuticals and related products. The company's expertise encompasses the development, manufacture, marketing, and sale of high-quality veterinary medicines. Its product portfolio includes both novel and differentiated generic pharmaceuticals, with a significant focus on products for companion animals. Dechra provides solutions and support to veterinary professionals worldwide to improve animal health and welfare.

Recent filings

Filing Released Lang Actions
Acquisition of Med-Pharmex, Inc
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and explicitly states it is released by Dechra Pharmaceuticals PLC, containing 'inside information' disclosed under MAR regulations. The content details a specific corporate action: the acquisition of Med-Pharmex, Inc. This type of announcement, which is a material corporate event disclosure made via the Regulatory News Service (RNS), does not fit neatly into the specific categories like 10-K, ER, or CAP (which is for fundraising/financing structure changes, not M&A transactions themselves). While it relates to capital structure indirectly (funding via debt), the primary event is a merger/acquisition. However, none of the provided codes specifically cover M&A announcements (TAR is for 'merger proposals or takeover bids', which is close but this is a completed acquisition announcement). Given the source is RNS and it's a significant, non-standard filing that isn't a core financial report, the most appropriate general regulatory filing category is RNS, as it is a regulatory news service announcement.
2022-08-30 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 9568T' and the footer stating, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content details a 'TR-1: Standard form for notification of major holdings' concerning changes in voting rights thresholds (crossing below 5% from 5.030491%). This type of mandatory disclosure regarding significant changes in share ownership falls directly under the definition of 'Major Shareholding Notification' (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2022-07-27 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is an RNS announcement (indicated by 'RNS Number : 6697T' and the LSE footer) detailing a 'Notification of Transactions by Person Discharging Managerial Responsibilities' (PDMR). Specifically, it reports the purchase of ordinary shares by a Non-Executive Director (Ishbel Macpherson) and includes a formal 'Notification of Dealing Form' as required by UK Market Abuse Regulation. This type of insider transaction reporting by directors falls directly under the definition of Director's Dealing (DIRS). Although it is an RNS announcement, the content is highly specific to director transactions, making DIRS the most precise classification over the general RNS fallback.
2022-07-25 English
Results of Placing
Capital/Financing Update Classification · 98% confidence The document is an RNS announcement from Dechra Pharmaceuticals PLC dated July 21, 2022. The core content details the successful completion of a 'Placing' (offering) of new ordinary shares, raising gross proceeds of £180 million, and a concurrent 'Retail Offer'. It specifies the number of shares, the price, the bookrunner (Investec), and the expected admission to trading on the London Stock Exchange. This announcement concerns a significant capital raising/financing activity. This aligns directly with the definition for Capital/Financing Update (CAP). Although it is an RNS announcement, the primary subject matter is the capital raise itself, making CAP the most specific classification over the general RNS fallback.
2022-07-21 English
Retail Offer by PrimaryBid
Capital/Financing Update Classification · 98% confidence The document is an RNS announcement dated July 20, 2022, detailing a 'Retail Offer' of new ordinary shares at a specific issue price (3430p) via PrimaryBid, concurrent with an acquisition announcement. The core purpose is to announce the terms and mechanism for raising capital (Placing and Retail Offer). This clearly falls under the category of updates on company fundraising and capital structure changes. Therefore, the appropriate classification is Capital/Financing Update (CAP). Although it is distributed via RNS, the content is specific to a capital raise, making CAP more precise than the general RNS fallback.
2022-07-20 English
Acquisition and Placing
Capital/Financing Update Classification · 98% confidence The document is an official announcement released via RNS (RNS Number: 1973T) on July 20, 2022. The content details two major corporate actions: the agreement to acquire Piedmont Animal Health, Inc. and the intention to conduct a non-pre-emptive placing (Placing) and a Retail Offer to raise approximately £180 million to fund the acquisition and maintain balance sheet flexibility for future acquisitions. The announcement explicitly mentions the issuance of new ordinary shares ('Placing Shares' and 'Retail Offer Shares') and the associated capital raise. This combination of announcing a significant financing activity (issuing new shares) and an acquisition strongly aligns with the 'Capital/Financing Update' category (CAP). While it involves a transaction, the primary focus is the capital raise to fund it, which is a core component of CAP. It is not a full 10-K, an ER, or a simple DIV notice. Since it is a detailed announcement about fundraising, CAP is the most appropriate classification over the general RNS fallback.
2022-07-20 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.